TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cronos Australia Ltd. ( (AU:VIT) ) has issued an announcement.
Vitura Health Limited held its 2025 Annual General Meeting, where three resolutions were passed, and one was withdrawn. The meeting highlighted the company’s strategic focus on expanding its digital health platform and integrating new opportunities such as psychedelic product distribution, reinforcing its position in the medicinal cannabis and telehealth markets.
More about Cronos Australia Ltd.
Vitura Health Limited is a diversified digital health business listed on the ASX, operating through subsidiaries such as Burleigh Heads Cannabis, Canview, Doctors on Demand, Cortexa, CDA Clinics, and Cannadoc Health. The company focuses on the sale and distribution of medicinal cannabis and other therapeutic products, leveraging a comprehensive online ecosystem for prescribers, patients, and pharmacies. Vitura is also involved in telehealth services and aims to be a leading supplier of psychedelics for research and therapeutic use in Australia.
Average Trading Volume: 223,440
Technical Sentiment Signal: Sell
Current Market Cap: A$42.42M
Learn more about VIT stock on TipRanks’ Stock Analysis page.